DAX

EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda

Retrieved on: 
Wednesday, April 10, 2024
Annual, EUR, Supervisory board, Frankfurt Stock Exchange, CFO, DAX, Election, Messenger, SDAX, Bank statement, Annual general meeting, SCHOTT, Fine chemical

EQS-News: SCHOTT Pharma AG & Co. KGaA

Key Points: 
  • EQS-News: SCHOTT Pharma AG & Co. KGaA
    Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
    The issuer is solely responsible for the content of this announcement.
  • Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
    SCHOTT Pharma's first Annual General Meeting was held virtually on March 14, 2024
    SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, held its first Annual General Meeting today.
  • The Annual General Meeting took place virtually and allowed shareholders to interact directly and ask questions to the Management Board and Supervisory Board.
  • “Holding our first Annual General Meeting marks the next milestone in our capital market history.

Cvent Announces Agenda for its Cvent CONNECT Conference and Unveils First Keynote Speaker, Jennifer Morgan, Blackstone’s Global Head of Portfolio Operations & Former Co-CEO of SAP

Retrieved on: 
Thursday, March 14, 2024
Marketing, Data Management, Digital Marketing, Communications, Technology, Software, Content Marketing, CONNECT, Woman, DAX, Knowledge, Female, SAP, Risk management

Cvent, an industry-leading meetings, events and hospitality technology provider, unveiled the full agenda for its highly anticipated customer and industry conference, Cvent CONNECT .

Key Points: 
  • Cvent, an industry-leading meetings, events and hospitality technology provider, unveiled the full agenda for its highly anticipated customer and industry conference, Cvent CONNECT .
  • Jennifer Morgan, Global Head of Portfolio Operations at Blackstone and former Co-CEO of SAP, was the first conference keynote speaker to be announced as part of the agenda.
  • As the Global Head of Portfolio Operations at Blackstone, Jennifer leads the firm’s operating executives and advisors, who partner closely with Blackstone’s portfolio companies to accelerate, create, and safeguard value.
  • To view the full Cvent CONNECT agenda and to register for the conference, visit the Cvent CONNECT website.

EQS-News: Rational AG temporarily no longer in the MDAX after index rebalancing on 18 March 2024

Retrieved on: 
Wednesday, March 13, 2024
Supervisory board, Many, Food, MDAX, Social responsibility, Audit committee, DAX, Deutsch, News, Rational AG, Annual, Rationality

Landsberg am Lech, 6 March 2024 Following the quarterly index review by Deutsche Börse, Rational AG will be temporarily removed from the DAX family as of 18 March 2024.

Key Points: 
  • Landsberg am Lech, 6 March 2024 Following the quarterly index review by Deutsche Börse, Rational AG will be temporarily removed from the DAX family as of 18 March 2024.
  • This index criterion refers to Recommendation C.10 of the German Corporate Governance Code (GCGC), which requires the independence of the Audit Committee Chairman.
  • Membership of Deutsche Börse's DAX index family is of very high importance to the Executive Board and Supervisory Board of Rational AG.
  • Rational was floated in the Prime Standard of the German stock market in 2000 and is currently represented in the MDAX.

EQS-News: GEA sees earnings rise again in fiscal year 2023 and proposes dividend increase

Retrieved on: 
Wednesday, March 13, 2024
Annual general meeting, ROCE, Share repurchase, Supervisory board, GEA, Climate, Food, Growth, Treasury, Climate change, Health care, EUR, DAX, Organic, Policy, Annual, Environment, Renewable energy

Group revenue rose by 8.4 percent organically and by 4.0 percent on a reported basis to EUR 5,373 million.

Key Points: 
  • Group revenue rose by 8.4 percent organically and by 4.0 percent on a reported basis to EUR 5,373 million.
  • “In the face of the numerous challenges in fiscal year 2023, we managed to further improve our key financial figures.
  • EBITDA before restructuring expenses rose by EUR 62 million, or 8.7 percent, to EUR 774.3 million (2022: EUR 712.0 million).
  • Group profit for fiscal year 2023 came to EUR 392.8 million (2022: EUR 401.4 million).

EQS-News: Siltronic expands its Executive Board: Klaus Buchwald becomes Chief Operating Officer

Retrieved on: 
Wednesday, March 13, 2024
Senior, Supervisory board, Infineon Technologies, Computer, TecDAX, Growth, Silicon, Supply, MDAX, Wind, DAX, Frankfurt Stock Exchange, News, Head, Operation, Rohde & Schwarz, Management

Siltronic expands its Executive Board:

Key Points: 
  • Siltronic expands its Executive Board:
    Munich, Germany, March 12, 2024 – Effective August 1, 2024, the Supervisory Board has appointed Klaus Buchwald to the Executive Board of Siltronic AG.
  • The 55-year-old will assume the position of Chief Operating Officer (COO).
  • In his role, Mr. Buchwald will be primarily responsible for Operations and Supply Chain, Engineering and IT.
  • Furthermore, the existing division of responsibilities between CEO Dr. Michael Heckmeier and CFO Claudia Schmitt will remain unchanged.

WellSpan Health Advances Its Leadership in Delivering Exceptional Provider and Patient Experience with Nuance DAX Copilot

Retrieved on: 
Thursday, March 7, 2024
Interface (computing), Hospital, CVP, Investment, Physician, HIMSS, Health, EHR, American Medical Association, Documentation, WellSpan Health, Attention, DAX, Organization, KLAS, Patient, News, Microsoft, Nursing

BURLINGTON, Mass., March 7, 2024 /PRNewswire/ -- Nuance Communications, Inc., a Microsoft Company, today announced that WellSpan Health is advancing its leadership in providing high-quality provider and patient experiences by adding the Nuance Dragon® Ambient eXperience™ (DAX™) Copilot solution to its existing deployment of innovative solutions to automate and accelerate the creation of clinical documentation during exam room and telehealth visits.

Key Points: 
  • DAX Copilot, embedded within Epic, stands as the sole fully embedded ambient solution currently operational within Epic, with over 55 healthcare organizations.
  • WellSpan's selection of DAX Copilot is based on the long-standing trust and consistently productive working relationship it has with Nuance.
  • WellSpan Health facilities were also recognized for exemplary patient experience among the top 5 percent of U.S. hospitals in 2023 by Press Ganey, a leader in healthcare experience solutions and services.
  • For more information about Nuance DAX Copilot, please visit: www.nuance.com/DAXCopilot or visit us during HIMSS 2024 in Orlando, FL at booth #2741.

EQS-News: Parity still a long way off / FidAR Forum 2024 calls for substantial progress in increasing the proportion of women in management positions in Germany

Retrieved on: 
Monday, February 5, 2024
Supervisory board, SAP, Financial services, CFO, Hannover Re, DAX, Regulated market, ESMT, Sustainability, Old age, SDAX, Labour, Parity, Commerzbank, Salzgitter, MDAX, Bechtle, Management, Zalando, Federation, Hope, Siemens Healthineers, European School, Woman, BASF, Property management

Berlin, 31.01.2024: DAX companies are leading the way when it comes to equal participation of women in Germany.

Key Points: 
  • Berlin, 31.01.2024: DAX companies are leading the way when it comes to equal participation of women in Germany.
  • On the supervisory boards, the proportion of women is still just below the 40 per cent mark at 38.5 per cent.
  • Six supervisory boards at Hannover Re, Zalando, Commerzbank, Covestro, Heidelberg Materials and Vonovia have at least equal representation of women and men.
  • Substantial progress requires concrete strategies for sustainably increasing the proportion of women at all management levels.

EQS-News: Stefan Kühn: The stock market year 2023 in figures. Stefan Kühn takes stock.

Retrieved on: 
Tuesday, January 30, 2024
Bitcoin, DAX, Nature, Gold, Uncertainty, Policy, Platinum, Euphoria, Intelligence, Natural gas, United States Treasury security, AI, Government, News, Apple, Health, Cryptocurrency

The stock market year 2023, which differed significantly from its predecessor, was characterised by surprises and strong fluctuations.

Key Points: 
  • The stock market year 2023, which differed significantly from its predecessor, was characterised by surprises and strong fluctuations.
  • Stefan Kühn, experienced business economist and economist, sheds light on the challenges and opportunities of the stock market year 2023 and emphasises the importance of sound analysis and a flexible investment approach in a volatile market environment.
  • Stefan Kühn takes a look at the coming stock market year 2024 and presents his forecast, taking into account political and global economic trade relations as well as current government influence on the money market.
  • This forecast by Stefan Kühn reflects a general view of the stock market year 2024 and is based on current economic and political trends.

EQS-News: SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory

Retrieved on: 
Tuesday, January 30, 2024
DAX, Drug, Diabetes, Obesity, Patient, Frankfurt Stock Exchange, HVS, Glass, Syringe, CFO, DDS, SCHOTT, DCS, Annual, Cancer, Administration, Parkinson's disease, Insulin, Spacecraft, Supervisory board, Investment, SDAX, IPO, EUR, FY, Messenger, Growth, Fine chemical

“With our 2023 results, we have delivered on all our targets and have proven that SCHOTT Pharma is a highly profitable business.

Key Points: 
  • “With our 2023 results, we have delivered on all our targets and have proven that SCHOTT Pharma is a highly profitable business.
  • We will continue to benefit from key pharma trends and the overall market growth for injectable drugs”, said Almuth Steinkühler, CFO of SCHOTT Pharma.
  • In 2023, SCHOTT Pharma continued to deliver on its strategy and achieved several milestones along the pillars expansion and innovation.
  • On the innovation side, SCHOTT Pharma successfully introduced two leading innovations to the market that serve the pharma megatrends Glucagon-like peptide-1 (GLP-1) and mRNA.

EQS-News: GEA achieves key milestone: Science Based Targets initiative (SBTi) validates 2040 net-zero target

Retrieved on: 
Tuesday, January 30, 2024
Science Based Targets initiative, Carbon accounting, GEA, DAX, Climate, Investment, Science, GHG, Geography, Renewable energy

Duesseldorf (Germany), January 25, 2024 – The Science Based Targets initiative has validated GEA’s 2040 net-zero target.

Key Points: 
  • Duesseldorf (Germany), January 25, 2024 – The Science Based Targets initiative has validated GEA’s 2040 net-zero target.
  • This is based on a scientifically validated assessment of the climate targets and the associated reduction measures.
  • The SBTi validation confirms that GEA’s pathway to net zero is consistent with the Paris Climate Agreement.
  • “To achieve our climate targets, we have drawn up a comprehensive Climate Transition Plan 2040.